BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong F, Perdew GH. The aryl hydrocarbon receptor as a mediator of host-microbiota interplay. Gut Microbes 2020;12:1859812. [PMID: 33382356 DOI: 10.1080/19490976.2020.1859812] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Cook TM, Mansuy-Aubert V. Communication between the gut microbiota and peripheral nervous system in health and chronic disease. Gut Microbes 2022;14:2068365. [PMID: 35482894 DOI: 10.1080/19490976.2022.2068365] [Reference Citation Analysis]
2 van den Bogaard EH, Esser C, Perdew GH. The aryl hydrocarbon receptor at the forefront of host-microbe interactions in the skin: A perspective on current knowledge gaps and directions for future research and therapeutic applications. Exp Dermatol 2021. [PMID: 34105853 DOI: 10.1111/exd.14409] [Reference Citation Analysis]
3 Dopkins N, Neameh WH, Hall A, Lai Y, Rutkovsky A, Gandy AO, Lu K, Nagarkatti PS, Nagarkatti M. Effects of Acute 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Exposure on the Circulating and Cecal Metabolome Profile. Int J Mol Sci 2021;22:11801. [PMID: 34769237 DOI: 10.3390/ijms222111801] [Reference Citation Analysis]
4 Puccetti M, Pariano M, Renga G, Santarelli I, D'Onofrio F, Bellet MM, Stincardini C, Bartoli A, Costantini C, Romani L, Ricci M, Giovagnoli S. Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting. Cells 2021;10:1601. [PMID: 34202407 DOI: 10.3390/cells10071601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Coquant G, Aguanno D, Pham S, Grellier N, Thenet S, Carrière V, Grill JP, Seksik P. Gossip in the gut: Quorum sensing, a new player in the host-microbiota interactions. World J Gastroenterol 2021; 27(42): 7247-7270 [PMID: 34876787 DOI: 10.3748/wjg.v27.i42.7247] [Reference Citation Analysis]
6 Renga G, Nunzi E, Pariano M, Puccetti M, Bellet MM, Pieraccini G, D'Onofrio F, Santarelli I, Stincardini C, Aversa F, Riuzzi F, Antognelli C, Gargaro M, Bereshchenko O, Ricci M, Giovagnoli S, Romani L, Costantini C. Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite. J Immunother Cancer 2022;10:e003725. [PMID: 35236743 DOI: 10.1136/jitc-2021-003725] [Reference Citation Analysis]
7 Leigh SJ, Lynch CMK, Bird BRH, Griffin BT, Cryan JF, Clarke G. Gut microbiota-drug interactions in cancer pharmacotherapies: implications for efficacy and adverse effects. Expert Opin Drug Metab Toxicol 2022. [PMID: 35176217 DOI: 10.1080/17425255.2022.2043849] [Reference Citation Analysis]
8 Dai G, Chen X, He Y. The Gut Microbiota Activates AhR Through the Tryptophan Metabolite Kyn to Mediate Renal Cell Carcinoma Metastasis. Front Nutr 2021;8:712327. [PMID: 34458309 DOI: 10.3389/fnut.2021.712327] [Reference Citation Analysis]
9 de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. [DOI: 10.1136/gutjnl-2021-326789] [Reference Citation Analysis]
10 Tennoune N, Andriamihaja M, Blachier F. Production of Indole and Indole-Related Compounds by the Intestinal Microbiota and Consequences for the Host: The Good, the Bad, and the Ugly. Microorganisms 2022;10:930. [DOI: 10.3390/microorganisms10050930] [Reference Citation Analysis]